Crossmark

Personalizing the safe, appropriate and effective concentration(s) of ozone for a non-diabetic individual and four type II diabetic patients in autohemotherapy through blood hemoglobin analysis

Crossref DOI link: https://doi.org/10.1186/s12967-019-1973-5

Published Online: 2019-07-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mehraban, Fouad

Seyedarabi, Arefeh http://orcid.org/0000-0003-4234-9799
Ahmadian, Shahin

Mirzaaghaei, Vahid

Moosavi-Movahedi, Ali Akbar
License Information

Text and Data Mining valid from 2019-07-16

Version of Record valid from 2019-07-16
More Information

Article History

Received: 3 April 2019

Accepted: 5 July 2019

First Online: 16 July 2019

Ethics approval and consent to participate

: Consent was obtained for blood sample collection from the five human subjects in this study (ethics code: IR.UT.SPORT.REC.1397.038).

: Consent is given for publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below